Date | Open(₹) | High(₹) | Low(₹) | Close(₹) | No. Of Trades(₹) | Total Turnover(₹) | Deliverable Quantity(₹) |
|---|---|---|---|---|---|---|---|
11-Mar-2026 | 503.9 | 515 | 494 | 507.25 | 11,347 | 16,91,22,518.2 | 1,37,264 |
12-Mar-2026 | 507.2 | 507.25 | 493.2 | 498.95 | 7,392 | 8,99,80,204.45 | 75,945 |
13-Mar-2026 | 497.9 | 497.9 | 468 | 470.3 | 8,078 | 9,99,40,658.55 | 1,00,567 |
16-Mar-2026 | 468 | 481.15 | 461.4 | 463.7 | 8,782 | 6,37,42,693.2 | 51,841 |
17-Mar-2026 | 462 | 472 | 456.55 | 463.85 | 8,319 | 6,93,38,843.65 | 71,932 |
18-Mar-2026 | 463 | 485 | 463 | 481.3 | 4,689 | 4,49,55,379.4 | 43,566 |
19-Mar-2026 | 477 | 477 | 464.85 | 468.2 | 8,172 | 4,07,63,719.05 | 48,786 |
20-Mar-2026 | 468.2 | 487.65 | 468.2 | 483.4 | 8,095 | 5,97,59,604.35 | 53,343 |
23-Mar-2026 | 482.9 | 483 | 463 | 467.4 | 4,645 | 5,17,57,133.15 | 62,173 |
24-Mar-2026 | 471.9 | 482 | 466.2 | 477.7 | 6,794 | 5,84,97,313.35 | 59,444 |
25-Mar-2026 | 478.8 | 497 | 478.8 | 493.65 | 5,903 | 6,25,75,660.5 | 69,274 |
27-Mar-2026 | 492.1 | 492.95 | 470.1 | 474.35 | 12,904 | 17,56,51,473.1 | 2,43,160 |
30-Mar-2026 | 467.1 | 472 | 458.4 | 466.1 | 10,025 | 8,02,05,806 | 84,819 |
01-Apr-2026 | 473.9 | 499.95 | 473.9 | 496.45 | 7,171 | 8,16,87,094.2 | 82,680 |
02-Apr-2026 | 490 | 504 | 479.55 | 499.05 | 6,828 | 7,99,47,606.2 | 71,953 |
06-Apr-2026 | 496.3 | 498.75 | 482.6 | 493.35 | 4,740 | 5,89,97,228.65 | 47,612 |
07-Apr-2026 | 490.1 | 498.5 | 488 | 489.55 | 3,462 | 4,44,81,288.25 | 49,441 |
08-Apr-2026 | 496 | 515 | 495 | 504.9 | 6,038 | 10,63,63,515.35 | 1,08,257 |
09-Apr-2026 | 504 | 519.6 | 490.25 | 491.75 | 6,099 | 11,55,86,145.7 | 1,29,805 |
The organisation is the largest CDMO serving the Indian pharmaceutical industry, with a proven track record and a broad clientele.
The IPO comprised a fresh issue of shares worth ₹680 crore and an offer-for-sale (OFS) of 1.73 crore shares, aggregating ₹1,177 crore.
The IPO consists of a fresh issue of ₹680 crore and an offer for sale (OFS) of up to 1.73 crore shares at a face value of ₹2 each.
On Monday, the business said that it had received ₹829 crore from anchor investors ahead of the public share sale subscription period.
The IPO includes a new issue of 1 Crore shares worth ₹680.00 Crore and an offer for sale of 1.73 Crore shares worth ₹1,176.74 Crore.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
